09/21/2026 | Press release | Distributed by Public on 09/21/2026 15:08
COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.
Read Announcement View Product PhotosGlobal Mix Inc. of Middle Village, New York, is recalling niwali Tejocote Capsules (90 capsules, Herbal Supplement) and niwali Tejocote Pieces (90 Day Supply, Herbal Supplement) because FDA analysis has determined that the products appear to be Thevetia peruviana, or yellow oleander. All parts of the yellow oleander plant are known to contain cardiac glycosides, which are highly toxic to humans and animals. Ingestion of yellow oleander can cause severe or even fatal neurologic, gastrointestinal, and cardiovascular adverse health effects. Symptoms may include nausea, vomiting, dizziness, diarrhea, abdominal pain, changes in heart rhythm, arrhythmia, and more.
The products were distributed nationwide within the United States through ebay.com and Everymarket.com. A total of five units of the recalled products were sold, consisting of two (2) units of capsules and three (3) units of pieces. Because the sales were made through an online marketplace that does not release purchaser contact details to the seller, the company is unable to identify or notify every purchaser individually. The company is therefore issuing this press release so that any consumer who purchased the products can identify them and act on this notice.
Product identification
niwali Tejocote Capsules
| Product name | niwali Tejocote Capsules - 90 Count, Herbal Supplement |
| Brand | Niwali |
| Package | White plastic bottle with white screw cap, blue and green label bearing the "niwali" logo, marked "Tejocote Capsules", "90 CAPSULES", "HERBAL SUPPLEMENT" |
| UPC / item code | N/A |
| Lot / batch code | RM500925 |
| Best by / expiration date | 03/03/2028 |
| Where sold | Ebay.com and Everymarket.com |
niwali Tejocote Pieces
| Product name | niwali Tejocote Pieces - 90 Day Supply, Herbal Supplement |
| Brand | Niwali |
| Package | Bottle with a blue and white wrap-around label bearing the "niwali" logo, marked "Tejocote Pieces", "90 DAY SUPPLY", "HERBAL SUPPLEMENT". The Supplement Facts panel states serving size 1 piece, 90 servings per container, TejoMax Formula (Tejocote root) 78 mg. The label carries the statement "Distributed by Niwali, 20533 Biscayne Bay Drive, Suite 4, Aventura, Florida 33180". |
| UPC / item code | 1 99284 23789 6 |
| Lot / batch code | RM400925 |
| Best by / expiration date | 03/03/2028 |
| Where sold | Ebay.com and Everymarket.com |
Reported illnesses
No illnesses or adverse events have been reported to the company to date in connection with the recalled products.
How the problem was discovered
The recall was initiated after the U.S. Food and Drug Administration advised the company of laboratory results for two samples collected by the agency on June 19, 2026, which showed that the products labeled as tejocote were in fact toxic yellow oleander. The company acted promptly on that information, ceased distribution of the affected products, removed the listings from sale, and is conducting this voluntary recall while it investigates the problem.
What consumers should do
Consumers who have purchased niwali Tejocote Capsules or niwali Tejocote Pieces should stop using them immediately and should not consume any remaining product. Consumers should return the products to the place of purchase for a full refund, or contact the company at the number below to arrange a refund. Consumers with questions may contact Global Mix Inc. Customer Service at (646) 419-5884 Monday to Friday, 9:00 a.m. to 5:00 p.m. Eastern Time, or by email at [email protected] . Further information about this recall is available at www.globalmixinc.com.
Consumers who have consumed the product and who have concerns about their health should contact a healthcare provider. Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program by telephone at 1-800-FDA-1088.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
09/21/2026